Amylyx Pharmaceuticals Inc’s recent filing unveils that its Director Firestone Karen acquired Company’s shares for reported $0.11 million on Sep 05 ’24. In the deal valued at $2.13 per share,50,000 shares were bought. As a result of this transaction, Firestone Karen now holds 55,000 shares worth roughly $0.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MILNE GEORGE M JR bought 100,000 shares, generating $219,800 in total proceeds. Upon buying the shares at $2.20, the Director now owns 858,571 shares.
Before that, Quimi Daphne bought 2,750 shares. Amylyx Pharmaceuticals Inc shares valued at $5,184 were divested by the Director at a price of $1.89 per share. As a result of the transaction, Quimi Daphne now holds 2,750 shares, worth roughly $7205.0.
Mizuho downgraded its Amylyx Pharmaceuticals Inc [AMLX] rating to a Neutral from a a Buy in a research note published on March 18, 2024; the price target was decreased to $4 from $32. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Neutral”. Leerink Partners also remained covering AMLX and has decreased its forecast on March 11, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Goldman revised its rating on March 08, 2024. It rated AMLX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of AMLX
On Friday, Amylyx Pharmaceuticals Inc [NASDAQ:AMLX] saw its stock jump 5.22% to $2.62. Over the last five days, the stock has gained 10.55%. Amylyx Pharmaceuticals Inc shares have fallen nearly -82.20% since the year began. Nevertheless, the stocks have fallen -86.98% over the past one year. While a 52-week high of $20.99 was reached on 02/29/24, a 52-week low of $1.58 was recorded on 06/17/24. SMA at 50 days reached $2.11, while 200 days put it at $6.80.
Levels Of Support And Resistance For AMLX Stock
The 24-hour chart illustrates a support level at 2.50, which if violated will result in even more drops to 2.39. On the upside, there is a resistance level at 2.71. A further resistance level may holdings at 2.81. The Relative Strength Index (RSI) on the 14-day chart is 66.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.21%. Stochastics %K at 78.63% indicates the stock is a holding.
How much short interest is there in Amylyx Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amylyx Pharmaceuticals Inc stocks on 2024-08-30, dropping by -0.37 million shares to a total of 1.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 1.86 million shares. There was a decline of -24.82%, which implies that there is a negative sentiment for the stock.
